Equitable Trust Co. Buys 2,271 Shares of Addus HomeCare Co. (NASDAQ:ADUS)

Equitable Trust Co. grew its stake in shares of Addus HomeCare Co. (NASDAQ:ADUS) by 47.1% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 7,096 shares of the company’s stock after purchasing an additional 2,271 shares during the period. Equitable Trust Co.’s holdings in Addus HomeCare were worth $889,000 as of its most recent SEC filing.

A number of other large investors have also recently modified their holdings of ADUS. Wasatch Advisors LP boosted its stake in Addus HomeCare by 11.8% during the third quarter. Wasatch Advisors LP now owns 1,043,240 shares of the company’s stock worth $138,782,000 after acquiring an additional 110,010 shares in the last quarter. State Street Corp boosted its stake in Addus HomeCare by 4.4% during the third quarter. State Street Corp now owns 663,610 shares of the company’s stock worth $88,280,000 after acquiring an additional 27,990 shares in the last quarter. Principal Financial Group Inc. boosted its stake in Addus HomeCare by 17.5% during the third quarter. Principal Financial Group Inc. now owns 505,853 shares of the company’s stock worth $67,293,000 after acquiring an additional 75,409 shares in the last quarter. WCM Investment Management LLC boosted its stake in Addus HomeCare by 2.9% during the third quarter. WCM Investment Management LLC now owns 498,279 shares of the company’s stock worth $65,250,000 after acquiring an additional 13,938 shares in the last quarter. Finally, Geode Capital Management LLC boosted its stake in Addus HomeCare by 7.1% during the third quarter. Geode Capital Management LLC now owns 423,934 shares of the company’s stock worth $56,406,000 after acquiring an additional 28,284 shares in the last quarter. Institutional investors own 95.35% of the company’s stock.

Addus HomeCare Stock Up 0.3 %

ADUS opened at $116.46 on Tuesday. The firm has a 50 day moving average price of $126.62 and a 200-day moving average price of $127.34. Addus HomeCare Co. has a twelve month low of $85.94 and a twelve month high of $136.72. The stock has a market capitalization of $2.11 billion, a price-to-earnings ratio of 26.65, a PEG ratio of 1.55 and a beta of 1.00.

Insider Activity

In other Addus HomeCare news, CEO R Dirk Allison sold 12,500 shares of the stock in a transaction that occurred on Monday, November 25th. The shares were sold at an average price of $123.16, for a total value of $1,539,500.00. Following the transaction, the chief executive officer now directly owns 141,897 shares in the company, valued at approximately $17,476,034.52. This trade represents a 8.10 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Roberton James Stevenson sold 2,250 shares of the stock in a transaction that occurred on Monday, December 9th. The stock was sold at an average price of $121.00, for a total transaction of $272,250.00. Following the completion of the transaction, the executive vice president now owns 10,217 shares in the company, valued at $1,236,257. The trade was a 18.05 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 39,750 shares of company stock valued at $4,930,750 over the last three months. Insiders own 4.60% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on ADUS shares. JMP Securities started coverage on shares of Addus HomeCare in a research note on Monday, December 16th. They set an “outperform” rating and a $150.00 price objective on the stock. Royal Bank of Canada reissued an “outperform” rating and set a $136.00 price objective on shares of Addus HomeCare in a research note on Thursday, November 14th. Stephens lifted their target price on shares of Addus HomeCare from $143.00 to $145.00 and gave the stock an “overweight” rating in a report on Wednesday, November 6th. Citizens Jmp raised shares of Addus HomeCare to a “strong-buy” rating in a report on Monday, December 16th. Finally, StockNews.com raised shares of Addus HomeCare from a “hold” rating to a “buy” rating in a report on Friday, January 24th. One equities research analyst has rated the stock with a sell rating, eight have issued a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat, the stock has an average rating of “Buy” and a consensus price target of $134.22.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.